EA200301275A1 - Капсулы для ингаляции - Google Patents

Капсулы для ингаляции

Info

Publication number
EA200301275A1
EA200301275A1 EA200301275A EA200301275A EA200301275A1 EA 200301275 A1 EA200301275 A1 EA 200301275A1 EA 200301275 A EA200301275 A EA 200301275A EA 200301275 A EA200301275 A EA 200301275A EA 200301275 A1 EA200301275 A1 EA 200301275A1
Authority
EA
Eurasian Patent Office
Prior art keywords
inhalation
capsules
stable
contain
active ingredient
Prior art date
Application number
EA200301275A
Other languages
English (en)
Other versions
EA005188B1 (ru
Inventor
Дитер Хохрайнер
Каролине Бехтольд-Петерс
Михаэль Трунк
Михаэль Вальц
Original Assignee
Бёрингер Ингельхайм Фарма Гмбх Унд Ко. Кг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7687020&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200301275(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Бёрингер Ингельхайм Фарма Гмбх Унд Ко. Кг filed Critical Бёрингер Ингельхайм Фарма Гмбх Унд Ко. Кг
Publication of EA200301275A1 publication Critical patent/EA200301275A1/ru
Publication of EA005188B1 publication Critical patent/EA005188B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/001—Particle size control
    • A61M11/003—Particle size control by passing the aerosol trough sieves or filters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0033—Details of the piercing or cutting means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

В заявке описаны капсулы для ингаляции (ингалетки), которые выполнены из особых материалов с пониженным влагосодержанием и которые содержат в качестве действующего вещества тиотропий в виде порошковых композиций и отличаются повышенной стабильностью.Отчет о международном поиске был опубликован 2003.09.12.
EA200301275A 2001-06-01 2002-05-27 Капсулы для ингаляции EA005188B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10126924A DE10126924A1 (de) 2001-06-01 2001-06-01 Inhalationskapseln
PCT/EP2002/005600 WO2002098874A2 (de) 2001-06-01 2002-05-27 Inhalationskapseln

Publications (2)

Publication Number Publication Date
EA200301275A1 true EA200301275A1 (ru) 2004-06-24
EA005188B1 EA005188B1 (ru) 2004-12-30

Family

ID=7687020

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200301275A EA005188B1 (ru) 2001-06-01 2002-05-27 Капсулы для ингаляции

Country Status (37)

Country Link
EP (2) EP1379220B1 (ru)
JP (3) JP4447311B2 (ru)
KR (2) KR100921904B1 (ru)
CN (3) CN1512875A (ru)
AR (2) AR034346A1 (ru)
AT (1) ATE285752T1 (ru)
AU (2) AU2002344354B2 (ru)
BG (1) BG65655B1 (ru)
BR (1) BR0209366A (ru)
CA (1) CA2448425C (ru)
CH (1) CH1379220H1 (ru)
CO (1) CO5540379A2 (ru)
CZ (1) CZ300284B6 (ru)
DE (2) DE10126924A1 (ru)
EA (1) EA005188B1 (ru)
EC (2) ECSP034868A (ru)
EE (1) EE05416B1 (ru)
EG (1) EG24227A (ru)
ES (1) ES2236590B5 (ru)
HR (1) HRP20030993B1 (ru)
HU (3) HU230058B1 (ru)
IL (2) IL158917A0 (ru)
ME (1) ME00301B (ru)
MX (1) MXPA03010990A (ru)
MY (1) MY126253A (ru)
NO (1) NO332857B3 (ru)
NZ (1) NZ530356A (ru)
PE (1) PE20030071A1 (ru)
PL (2) PL203801B1 (ru)
PT (1) PT1379220E (ru)
RS (1) RS50353B (ru)
SI (1) SI1379220T1 (ru)
SK (2) SK287346B6 (ru)
TW (1) TWI327921B (ru)
UA (1) UA75659C2 (ru)
WO (1) WO2002098874A2 (ru)
ZA (1) ZA200308340B (ru)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1292281B1 (de) 2000-10-12 2004-09-08 Boehringer Ingelheim Pharma GmbH & Co.KG Neue tiotropium-haltige inhalationspulver
DE10126924A1 (de) * 2001-06-01 2002-12-05 Boehringer Ingelheim Pharma Inhalationskapseln
DE10212264A1 (de) 2002-03-20 2003-10-02 Boehringer Ingelheim Pharma Kristallines Mikronisat, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels
AU2003228907A1 (en) * 2002-05-07 2003-11-11 Nektar Therapeutics Capsules for dry powder inhalers and methods of making and using same
DE10255387A1 (de) * 2002-11-28 2004-06-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Tiotropium-haltige Pulverformulierung für die Inhalation
US7763280B2 (en) 2002-11-28 2010-07-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation
DE10258360A1 (de) * 2002-12-12 2004-06-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pulverinhalator mit Kapselkammer zum Aufnehmen einer mit Wirkstoff gefüllten Einwegkapsel
DE10352277A1 (de) * 2003-11-08 2005-06-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pulverinhalator
SE0303269L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Medicinsk produkt
SE0303570L (sv) 2003-12-03 2005-06-04 Microdrug Ag Fukt-känslig medicinsk produkt
GB0503738D0 (en) * 2005-02-23 2005-03-30 Optinose As Powder delivery devices
US7694676B2 (en) 2005-04-22 2010-04-13 Boehringer Ingelheim Gmbh Dry powder inhaler
JP4825455B2 (ja) * 2005-05-02 2011-11-30 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 粉末吸入器
DE102006016904A1 (de) 2006-04-11 2007-10-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalator
DE102006016901A1 (de) * 2006-04-11 2007-10-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Mundstück für einen Inhalator
GB0716026D0 (en) * 2007-08-16 2007-09-26 Norton Healthcare Ltd An inhalable medicament
DE102007036411A1 (de) 2007-07-20 2009-02-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pulverinhalator
DE102007052871A1 (de) * 2007-11-02 2009-05-07 Boehringer Ingelheim Pharma Gmbh & Co. Kg Kapsel zur Aufnahme von pharmazeutischen Wirkstoffformulierungen
JP2011512175A (ja) * 2008-02-08 2011-04-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング カプセル充填方法及び装置
EP2172190A1 (en) * 2008-10-02 2010-04-07 Laboratorios Liconsa, S.A. Inhalable particles comprising tiotropium
ES2739352T3 (es) 2009-02-26 2020-01-30 Glaxo Group Ltd Formulaciones farmacéuticas que comprenden 4-{(1R)-2-[(6-{2-[(2,6-diclorobencil)oxi]etoxi}hexil)amino]-1-hidroxietil}-2-(hidroximetil)fenol
WO2010110760A1 (en) * 2009-03-27 2010-09-30 Mahmut Bilgic Compositions comprising water with deuterium for the prevention or treatment of allergic diseases and a process for the preparation thereof
GB0921075D0 (en) 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents
EP2575786B1 (en) 2010-06-03 2017-11-15 Sima Patent ve Lisanslama Hizmetleri Ltd.Sti. Process for dry powder formulations
DE202011102694U1 (de) 2011-06-29 2011-12-19 Zisser Gmbh Inhalationsgerät für Heimanwender
GB201200525D0 (en) 2011-12-19 2012-02-29 Teva Branded Pharmaceutical Prod R & D Inc An inhalable medicament
GEP201706672B (en) 2012-07-05 2017-05-25 Arven Ilac Sanayi Ve Ticaret As Dry powder inhaler compositions comprising long acting muscorinic antagonists
DE202013000774U1 (de) 2013-01-21 2013-04-15 Rhinofilt GmbH Miniaturisiertes Inhalationsgerät zur Privatanwendung
US10034866B2 (en) 2014-06-19 2018-07-31 Teva Branded Pharmaceutical Products R&D, Inc. Inhalable medicament comprising tiotropium
CN108295042A (zh) * 2018-03-05 2018-07-20 上海祺宇生物科技有限公司 一种用于吸入药剂的植物空心胶囊及其胶囊剂
CN108451920A (zh) * 2018-03-14 2018-08-28 绍兴康可胶囊有限公司 一种吸雾式胶囊及其制备方法
CN114848605B (zh) * 2022-03-25 2023-08-11 上海方予健康医药科技有限公司 一种供吸入粉雾剂用的明胶胶囊

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931041C2 (de) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
AU660824B2 (en) * 1992-06-12 1995-07-06 Teijin Limited Pharmaceutical preparation for intra-airway administration
US6228394B1 (en) * 1997-10-14 2001-05-08 Boehringer Ingelheim Pharmaceuticals, Inc. Supercritical fluid extraction of mould lubricant from hard shell capsules
DE19835346A1 (de) * 1998-08-05 2000-02-10 Boehringer Ingelheim Pharma Zweiteilige Kapsel zur Aufnahme von pharmazeutischen Zubereitungen für Pulverinhalatoren
JP2000143502A (ja) * 1998-11-11 2000-05-23 Shionogi Qualicaps Kk 吸入製剤
CA2347856C (en) * 1998-11-13 2009-02-17 Jago Research Ag Dry powder for inhalation
DE19921693A1 (de) * 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
EP1072258A1 (de) * 1999-07-28 2001-01-31 Greither, Peter Eine Kapsel für die Freisetzung von Bakterien, enthaltend ein Bakterienlyophilisat und ein Verfahren zu ihrer Herstellung
AU7685200A (en) * 1999-10-12 2001-04-23 Kaken Pharmaceutical Co., Ltd. Powdery inhalational preparations and process for producing the same
DE10126924A1 (de) * 2001-06-01 2002-12-05 Boehringer Ingelheim Pharma Inhalationskapseln

Also Published As

Publication number Publication date
ECSP034868A (es) 2004-03-23
KR20090010140A (ko) 2009-01-28
BG65655B1 (bg) 2009-05-29
HU230058B1 (hu) 2015-06-29
JP2008050364A (ja) 2008-03-06
AU2008203057A1 (en) 2008-07-31
JP4447311B2 (ja) 2010-04-07
HU230827B1 (hu) 2018-07-30
CN1512875A (zh) 2004-07-14
TWI327921B (en) 2010-08-01
NO332857B1 (no) 2013-01-21
HUP0400666A3 (en) 2009-06-29
JP4787034B2 (ja) 2011-10-05
MY126253A (en) 2006-09-29
CO5540379A2 (es) 2005-07-29
YU93503A (sh) 2006-05-25
EP1379220A2 (de) 2004-01-14
ES2236590T3 (es) 2005-07-16
SK287346B6 (sk) 2010-07-07
WO2002098874A3 (de) 2003-09-12
MXPA03010990A (es) 2004-02-27
AU2008203057B2 (en) 2011-12-08
CH1379220H1 (ru) 2018-10-31
ES2236590B5 (es) 2018-03-05
AR084804A2 (es) 2013-06-26
KR100921904B1 (ko) 2009-10-16
UA75659C2 (en) 2006-05-15
CZ300284B6 (cs) 2009-04-08
NO20035265D0 (no) 2003-11-27
ECSP11004868A (es) 2011-02-28
AU2008203057C8 (en) 2017-04-06
CA2448425A1 (en) 2002-12-12
HU231082B1 (hu) 2020-06-29
ATE285752T1 (de) 2005-01-15
EE200300595A (et) 2004-02-16
ZA200308340B (en) 2004-05-21
PE20030071A1 (es) 2003-03-04
BG108380A (en) 2004-11-30
HUP1500188A2 (en) 2005-03-29
EE05416B1 (et) 2011-06-15
HRP20030993A2 (en) 2005-08-31
PL205714B1 (pl) 2010-05-31
AU2008203057C1 (en) 2017-05-18
NO332857B3 (no) 2016-01-25
PL387118A1 (pl) 2004-12-13
IL158917A (en) 2008-11-03
JP2006143747A (ja) 2006-06-08
EG24227A (en) 2008-11-10
PL364108A1 (en) 2004-12-13
PL203801B1 (pl) 2009-11-30
MEP42508A (en) 2011-02-10
EA005188B1 (ru) 2004-12-30
CN101697965A (zh) 2010-04-28
KR20040007638A (ko) 2004-01-24
AR034346A1 (es) 2004-02-18
SI1379220T1 (en) 2005-04-30
EP1508330A1 (de) 2005-02-23
NO20035265L (no) 2003-11-27
KR100952321B1 (ko) 2010-04-09
SK16202003A3 (sk) 2004-05-04
RS50353B (sr) 2009-11-10
HUP0400666A2 (hu) 2005-03-29
DE10126924A1 (de) 2002-12-05
EP1379220B1 (de) 2004-12-29
CN101829072A (zh) 2010-09-15
AU2002344354B2 (en) 2008-08-07
CA2448425C (en) 2010-12-21
DE50201898D1 (de) 2005-02-03
BR0209366A (pt) 2004-06-08
ME00301B (me) 2011-05-10
SK287379B6 (sk) 2010-08-09
NZ530356A (en) 2005-05-27
HRP20030993B1 (en) 2011-10-31
WO2002098874A2 (de) 2002-12-12
IL158917A0 (en) 2004-05-12
CZ20033579A3 (en) 2004-05-12
JP2005500279A (ja) 2005-01-06
PT1379220E (pt) 2005-03-31

Similar Documents

Publication Publication Date Title
EA200301275A1 (ru) Капсулы для ингаляции
TW200633716A (en) Compositions and methods for stabilizing active pharmaceutical ingredients
HK1036931A1 (en) Pharmaceutical compositions containing compounds with activity for the enhancement of absorption of active ingredients.
NO20034230D0 (no) 1,2,3,4-tetrahydroisokinolin-derivater som urotensin II reseptor-antagonister
EA200401019A1 (ru) Дозированная лекарственная форма для перорального применения, содержащая ингибитор pde 4 в качестве действующего вещества и поливинилпирролидон в качестве вспомогательного вещества
CA2420874A1 (en) Active ingredient combinations with insecticidal and acaricidal properties
HUP0400832A3 (en) New amidoalkyl-piperidine and amidoalkyl-piperazine derivatives, and pharmaceutical compositions containing such derivatives as active ingredients
ATE311373T1 (de) Oxadiazolverbindungen und -zusammensetzungen zur abgabe von wirkstoffen
WO2001072125A3 (de) Wirkstoffkombinationen mit insektiziden und akariziden eigenschaften
MXPA03007857A (es) Compuestos y composiciones para entregar agentes activos.
PT1121127E (pt) Composicoes farmaceuticas orais contendo buprenorfina
MY131488A (en) Low dose liquid entecavir formulations and use
EA200801614A1 (ru) Фармацевтическая композиция, содержащая монтелукаст
WO2005065639A3 (en) Novel pharmaceutical compositions
ITMI20022549A1 (it) Composizione quaternaria comprendente come sostanza attiva la propolis.
AU2003269871A1 (en) Radiosensitizer composition containing n-acetylphytosphingosine analogs and n,n-dimethyl-phytosphingosine analogs as the active ingredients
EA200300128A1 (ru) Фармацевтические композиции, содержащие карбонат лития
MXPA02012015A (es) Ligandos de receptores para integrinas.
ATE307579T1 (de) Pektin und ascorbinsäure enthaltende zusammensetzungen
WO2004071386A3 (en) Compositions comprising microcapsules containing magnetic nanoparticles and biologically active molecules, their preparation and use
SE0103210D0 (sv) New formulations and use thereof
TW200621304A (en) Pharmaceutical composition
ATE241983T1 (de) Paracetamol und drotaverin enthaltende zusammensetzung
ATE382363T1 (de) Pharmazeutische zusammensetzung enthaltend bulbophyllum
EA200500083A1 (ru) Фармацевтическая композиция для чрескожной доставки активного агента (варианты)

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KG MD TJ TM

MF4A Revocation of a eurasian patent as invalid entirely

Designated state(s): RU

MF4A Revocation of a eurasian patent as invalid entirely

Designated state(s): KZ